Arbutus Biopharma Corp (NASDAQ:ABUS) filed a Form 8-K with the Securities and Exchange Commission on January 16, 2026, disclosing a material event.
Arbutus Biopharma Corp's stock currently trades at $4.06 with a market capitalization of $897,500,261. The Healthcare company's stock moved following the disclosure.